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Introduction
Dysmenorrhea or menstrual cramping is one of the most
common problems seen in women’s health care. An
estimated 50% of menstruating women are affected.
The condition is most common between the ages of 15
and 25 years.1 Dysmenorrhea can be further classified
into primary and secondary dysmenorrhea. Primary
dysmenorrhea is defined as pain during menses in the
absence of an identifiable pathologic lesion, while in
secondary dysmenorrhea, a macroscopic pelvic patho-
logy is present. Primary dysmenorrhea is a disorder that
affects 40–90% of the female population of reproduc-
tive age.2–4 The etiology of primary dysmenorrhea is
not precisely understood, but most symptoms can be
explained by the action of uterine prostaglandins (PG),
particularly PGF2α. Patients with primary dysmen-
orrhea have higher PG levels in the endometrium and
menstrual blood.5–8 It is a common belief that primary
dysmenorrhea has its onset when ovulatory cycles
begin, usually 6–12 months after menarche, peaks dur-
ing the late teenage years and early twenties, then de-
clines gradually with age.
To date, only 3 studies have examined the natural
history of primary dysmenorrhea.9–11 Unfortunately,
the duration of longitudinal follow-up was relatively
short in these studies. Moreover, parity had a strong
influence on the natural history of primary dysmenor-
rhea, making the judgment of the impact of aging on
primary dysmenorrhea more ambiguous. The purpose
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Background: Menstrual pain can be alleviated after childbirth. The purpose of this observational study was to evaluate the
natural progression of menstrual pain among nulliparous women at their reproductive age.
Methods: A questionnaire-based study of perimenopausal women with a history of primary dysmenorrhea was performed.
The study subjects were recruited between July 1, 2001 and June 30, 2005. Severity of menstrual pain was graded using
a multidimensional scoring system.
Results: A total of 247 nulliparous women with primary dysmenorrhea were enrolled, and of these, 218 patients were
eligible for analysis. Patients who had more frequent intercourse (p = 0.016), fewer associated systemic symptoms
(p = 0.028), and use of oral contraceptive pills (p = 0.039) tended to have a higher chance of an improvement in dysmen-
orrhea after age 40. Multidimensional scoring distribution over chronologic age revealed that patients had significantly
improved menstrual pain after 40 years of age.
Conclusion: For nulliparous women with primary dysmenorrhea, the severity of menstrual pain decreased significantly
after age 40. More studies are needed to explore this phenomenon from a biochemical or molecular basis. [J Chin Med
Assoc 2006;69(10):484–488]
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of this study was to evaluate the natural progression of
menstrual pain among women with primary dysmenor-
rhea who had never had children.
Methods
Study design
We conducted an observational hospital-based study
using data obtained from the Taipei Veterans General
Hospital Dysmenorrhea Record Database. To exclude
the effect of childbearing on dysmenorrhea, the tar-
geted study subjects were perimenopausal nulliparous
women with a history of primary dysmenorrhea. The
study subjects were recruited between July 2001 
and June 2005. The institutional review board of
Taipei Veterans General Hospital approved this study.
Study investigators were responsible for the iden-
tification of the original study subjects, and the re-
search panel performed the case registration and data
collection.
Patients and setting
The study subjects were nulliparous women over 40
years of age with a history of menstrual pain; when they
presented to the gynecologic clinic, they had reported
having had at least 1 episode of cramping pelvic pain
during menstruation that made them try taking pain-
relief drugs, or having had to be absent from school or
work. If the patient met the inclusion criteria, a study
investigator would invite her to participate in this study.
At the initial interview, full medical and gynecologic
histories were taken; physical examination was done
and, if needed, ultrasonography was performed. Then,
after obtaining their informed consent, patients were
asked to complete a 25-item validated questionnaire.
The questionnaire included items regarding demogra-
phic features, menstrual pattern, severity of menstrual
pain across chronologic age (menarche, age 20, 30,
40 and 45), impact of dysmenorrhea on school atten-
dance, job status, academic performance and social
activities.
The severity of dysmenorrhea was measured by a
multidimensional scoring system (MDS). The MDS
was modified from that devised by Biberoglu and
Berman.12 The scoring denotes dysmenorrhea accord-
ing to severity of dysmenorrhea as none (grade 0), mild
(grade 1), moderate (grade 2) and severe (grade 3)
based on pain, limited activities and medications taken
as shown in Table 1. For simplicity of statistical anal-
ysis, classification of MDS was further collapsed into 
2 categories, one for grade 0 and grade 1 and the other
for grades 2 and 3.
Patients were excluded if they had cramping pelvic
pain during menstruation that could be explained 
by local trauma, major pelvic trauma (e.g. traffic acci-
dent injury), specific food intake (e.g. icy food), severe
medical disorder, or other clearly non-gynecologic
pathology (e.g. inflammatory bowel disease, irritable
bowel syndrome, acute cystitis, interstitial cystitis). As
we intended to focus on primary dysmenorrhea, women
who reported endometriosis, pelvic inflammatory dis-
ease or uterine fibroids were also excluded from the
study.
Reassessment of dysmenorrhea
In order to maximize the reliability of data pres-
entation, participants were asked to come back to
complete the dysmenorrhea questionnaire again 1
month after the primary interview. If there was > 10%
difference in the visual analog scale or 1 grade diff-
erence in the MDS between the 2 consecutive eval-
uations for an individual patient, then that patient
underwent a repeated evaluation by a different study
investigator.
Data analysis and statistical methods
Data were collected on standardized forms and en-
coded for computerized analysis using SPSS version
10.0 (SPSS Inc., Chicago, IL, USA) for Windows;
flow chart was made using Visio 2003 (Microsoft Inc.,
Seattle, WA, USA), and figures were plotted using
Sigmaplot 2001 (SPSS Inc.). Continuous variables were
summarized by mean (range) or number (percent).
Comparisons of MDS between different chronologic
ages were made using repeated Mann–Whitney U test
with Scheffe’s correction or χ2 test, as appropriate.
Dependent categorical outcomes were analyzed with
McNemar test, while dependent continuous outcomes
were compared using the paired t test. Associations
denoted as statistically significant were those that
yielded a p value < 0.05, assuming a 2-sided alterna-
tive hypothesis.
Table 1. Multidimensional scoring of severity of dysmenorrhea
Grading Working ability
Systemic
Analgesics
symptoms
Mild Rarely None Rarely required
affected
Moderate Moderately Few Required
affected
Severe Clearly Apparent Poor effect
inhibited
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Results
Study sample
A total of 247 patients were recruited. Of these, 29
patients were excluded due to the following reasons:
17 had confirmed pelvic pathologies; 2 were diagnosed
with interstitial cystitis; 3 were diagnosed with irritable
bowel syndrome; 1 had pelvic trauma history; 6 had
incomplete data. The descriptive characteristics of the
218 eligible study subjects are shown in Table 2.
In order to find significant factors that correctly
predicted improvement of dysmenorrhea with age,
the study subjects were categorized into 2 groups. One
was the improvement group and the other was the non-
improvement group. The definition of improvement
was that the patient had been relieved by at least 1 grade
of MDS at age 40 as compared to age 20. At age 40,
136 patients (62.3%) had improvement in the severity
of dysmenorrhea. There were no significant differ-
ences between the improvement and non-improvement
groups with regard to patient age, menarche, men-
strual duration, menstrual interval, and body mass index.
The proportion of frequent intercourse (≥ 2 times/
week) was higher in the improvement group (36.7%)
versus the non-improvement group (23.1%; p = 0.016).
Patients who had fewer associated systemic symptoms
tended to have improved dysmenorrhea after age 40.
Patients who had ever used oral contraceptive pills for
more than 5 years also tended to have improved dys-
menorrhea compared to those who did not take pills.
Table 3 shows the distribution of MDS over chro-
nologic age. There were significantly more nulliparous
Table 2. Baseline characteristics of study patients (n = 218)*
Improvement Non-improvement 
p†
group (n = 136) group (n = 82)
Age (yr) 46 (45–51) 47 (45–52) 0.286
Age at menarche (yr) 12 (9–17) 13 (9–16) 0.658
Interval (yr)‡ 0.8 (0–3) 1.2 (0–4) 0.471
Duration of menstruation (d) 0.192
1–5 115 (84.5) 68 (82.9)
≥ 6 21 (15.6) 14 (17.1)
Menstrual interval (d) 0.811
< 21 8 (5.9) 6 (7.3)
21–35 116 (85.3) 68 (82.9)
> 36 12 (8.8) 8 (9.7)
Body mass index (kg/m2) 23.1 (15.9–39.6) 23.5 (16.7–40.8) 0.818
Abortus in first trimester 0.8 (0–3) 0.9 (0–4) 0.713
Intercourse (times/wk) 0.016
≥ 2 50 (36.7) 19 (23.1)
≤ 1 86 (63.2) 63 (76.9)
Associated symptoms§ 0.028
Yes 12 (8.8) 14 (16.9)
No 124 (91.2) 68 (82.9)
Use of oral contraceptive pills > 5 yr 0.039
Yes 28 (20.6) 6 (7.3)
No 108 (80.9) 76 (93.4)
Smoking 0.621
Yes 37 (27.2) 25 (30.4)
No 99 (72.8) 57 (69.5)
Alcohol user 0.818
Yes 32 (23.5) 21 (25.6)
No 104 (76.4) 61 (74.4)
*Data are presented as mean (range) or n (%), and sum of percentages may not total 100 due to rounding of figures; †Mann–Whitney U test with Scheffe’s 
correction or χ2 test as appropriate; ‡interval between menarche and onset of dysmenorrhea; §reported symptoms associated with dysmenorrhea included
fatigue, nausea, diarrhea, headache, backache, and epigastric pain.
women with primary dysmenorrhea who experienced
improvement in menstrual pain after age 40.
Table 4 presents the logistic regression analysis of
factors associated with improvement of dysmenorrhea
among nulliparous women after age 40. Two inde-
pendent factors were identified: normal weight and
oral contraceptive pill user were the 2 factors that pre-
dicted improvement of dysmenorrhea.
Discussion
The present study found that women with primary dys-
menorrhea who had never had children had a chance of
their menstrual pain improving after age 40. In con-
trast, a longitudinal study of young women between the
ages of 19 and 24 by Sundell et al13 showed that the
severity of dysmenorrhea only decreased in women who
had children during those 5 years, and was unchanged
in women who remained nulliparous, had a miscarriage
or had an abortion. Apparently, the length of follow-up
is the key factor in the outcome difference between
these 2 studies. A study by Weissman et al9 also found
that age had a significant effect on the severity of dys-
menorrhea, after adjusting for parity, indicating that
older women are more likely to experience a decrease
in the severity of dysmenorrhea, independent of child-
bearing. However, childbearing was clearly the more
influential factor in this analysis. In contrast, some stud-
ies found that childbearing had no significant impact on
improving severity of dysmenorrhea, after controlling
for age or age and smoking.14,15 The natural progres-
sion of menstrual pain is, thus, a very interesting issue
and deserves further study to investigate the underlying
pathophysiologic mechanisms.
There have been several studies on the impact of
oral contraceptive pills on the severity of dysmenorrhea.
The results indicate that oral contraceptive pills can
statistically and clinically significantly reduce the inci-
dence and severity of dysmenorrhea, and its impact on
daily activities.16–19 Our study further confirmed that
oral contraceptive pills had a positive impact on the sev-
erity of dysmenorrhea, on the condition that they were
used for longer than 5 years. Even in non-current users,
oral contraceptive pills can still ease the severity of dys-
menorrhea after age 40, implying that they may be able
to modify pain-triggering factors.
Our study also found that nulliparous women with
primary dysmenorrhea who had regular sexual inter-
course at a frequency of 2 or more times per week
could significantly diminish the severity of menstrual
pain after age 40. This phenomenon is hard to explain,
and deserves further in-depth investigation. Some
studies suggest that women who smoke, drink alcohol,
or who began menstruation early in life (before age 11)
have an increased risk of dysmenorrhea. On the con-
trary, our results did not corroborate such findings.
Owing to the observational nature of our study, the
results may not be so valid. Further controlled trials are
needed to resolve these questions. As for body weight,
the results of our report parallel those of previous
studies, indicating that overweight women have twice
the risk of non-improvement of menstrual pain after
age 40.
Dysmenorrhea-associated symptoms include fa-
tigue, nausea, diarrhea, headache, backache, and epigas-
tric pain. The current study demonstrated that there
was significant negative correlation between the pres-
ence of dysmenorrhea-associated symptoms and the
improvement of dysmenorrhea at age 40. Viewed
from another angle, if a woman with primary dysmen-
orrhea had no associated symptoms, she would more
easily get relief from dysmenorrhea at the age of 40
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Table 4. Multiple stepwise logistic regression analysis of 
independent factors associated with improvement in 
dysmenorrhea after 40 years of age
Variable OR 95% CI
Weight (BMI < 25 vs. ≥ 25) 2.16 1.49–2.85
Use of oral contraceptive pills 1.83 1.27–2.49
(≥ 5 yr vs. < 5 yr)
BMI = body mass index; OR = odds ratio; CI = confidence interval.
Table 3. Change in distribution of multidimensional scoring
(MDS) over chronologic age*
Age distribution (yr) Distribution of MDS† p
< 20 Mild: 124 (56.8) Reference
Moderate: 67 (30.9)
Severe: 27 (12.3)
20–29 None: 11 (5.0) 0.338
Mild: 120 (55.0)
Moderate: 61 (27.9)
Severe: 26 (11.9)
30–39 None: 19 (8.7) 0.173
Mild: 124 (56.9)
Moderate: 54 (24.8)
Severe: 21 (9.6)
≥ 40 None: 39 (17.9) 0.036
Mild: 123 (56.4)
Moderate: 42 (19.3)
Severe: 14 (6.4)
*Data are presented as n (%), and sum of percentages may not total 100 due
to rounding of figures; †estimated by McNemar’s 2 × 2 test, with none + mild
as one group, and moderate + severe as the other group.
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than women who had associated symptoms. We thus
hypothesize that among women with primary dysmen-
orrhea who had more associated systemic symptoms,
the etiologic factor(s) that induced the menstrual pain
were different from those in patients with fewer asso-
ciated systemic symptoms.
The major defect of the current study is that the
analysis was largely based on retrospective data. There-
fore, recall bias could be a concern. We had each
patient undergo 2 evaluations 1 month apart. If there
was > 10% discrepancy between the 2 consecutive
evaluations, a third evaluation was conducted. Thus,
the data were more reliable. Of course, a prospective
longitudinal survey would have made the study results
more convincing, but such a study takes more time
and effort.
In summary, nulliparous women with primary dys-
menorrhea may be relieved from menstrual pain after
the age of 40 years, especially in those who had frequent
sexual activity, those with fewer associated systemic
symptoms, and those who had used oral contraceptive
pills for longer than 5 years. More in-depth studies are
needed to explore the interrelationships among these
factors.
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